Study ID: PM033
Study Title
- Safety of New Formulation of Glatiramer Acetate
Teva Identifier
- PM033
ClinicalTrials.gov Identifier
- NCT00947752
Study Status
- Completed
Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
Interventions
- Drug: Glatiramer Acetate | Drug: Experimental Glatiramer Acetate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 07/01/2009 - 11/01/2009
Phase
- Phase 3
Study Type
Interventional
